four
known
acut
respiratori
syndrom
sar
type
human
coronavirus
hcov
detect
respiratori
specimen
sampl
hospitalis
children
four
hcov
detect
throughout
year
peak
circul
month
temper
climat
clinic
epidemiolog
characterist
studi
children
compar
three
group
children
hcov
identifi
mainli
children
upper
lower
respiratori
tract
infect
vs
signific
differ
clinic
present
three
coronaviru
group
low
associ
lower
respiratori
tract
ill
studi
show
nearli
children
admit
hospit
respiratori
tract
ill
suffer
underli
chronic
condit
prove
consider
risk
complic
hcov
may
also
respons
respiratori
nosocomi
therefor
critic
hcov
screen
routin
respiratori
specimen
hospit
reliabl
viral
detect
method
use
multiplex
revers
transcript
polymeras
chain
reaction
develop
studi
enabl
sensit
detect
characteris
known
hcov
type
except
septemb
may
paediatr
nasal
aspir
submit
laboratori
viral
detect
specimen
sampl
children
admit
univers
hospit
caen
gener
hospit
fler
respiratori
gener
symptom
parent
legal
guardian
patient
consent
sampl
test
respiratori
virus
routin
test
allow
detect
influenza
b
c
virus
respiratori
syncyti
virus
b
rsv
human
metapneumovirus
virus
adenoviru
enteroviru
rhinoviru
perform
use
immunofluoresc
assay
cultur
isol
molecular
method
previous
describ
seven
hundr
specimen
found
posit
total
number
sampl
cohort
specimen
repres
influenza
b
parainfluenza
human
remain
specimen
test
human
coronavirus
sampl
patient
age
year
sex
ratio
boy
vs
girl
age
distribut
sampl
popul
follow
patient
month
age
patient
month
age
patient
year
age
patient
year
age
total
sampl
popul
younger
year
old
monthli
distribut
sampl
show
nasal
aspir
sampl
decemb
april
multiplex
assay
develop
detect
hcov
simultan
rna
extract
use
high
pure
rna
isol
kit
roch
germani
amplif
differ
size
product
bp
type
bp
type
bp
type
bp
type
perform
use
primer
previous
describ
n
gene
three
genotyp
b
c
recent
describ
woo
et
al
order
allow
amplif
three
genotyp
origin
primer
design
genotyp
strain
referenc
genbank
degener
follow
sensmod
antisensemod
undertaken
use
kit
qiagen
courtaboeuf
franc
accord
manufactur
protocol
serial
manipul
neg
posit
control
includ
compar
analyt
sensit
four
singl
assay
one
multiplex
assay
studi
analys
serial
dilut
posit
control
found
equival
respect
intend
target
potenti
among
hcov
primer
elimin
analys
differ
combin
posit
control
product
process
agaros
gel
stain
ethidium
bromid
visualis
uv
light
sampl
posit
detect
amplifi
product
subject
hybridis
test
deia
sorin
itali
confirm
specif
amplifi
product
probe
use
previous
describ
hcov
sequenc
probe
degener
detect
three
genotyp
follow
patient
detect
retrospect
examin
medic
record
conduct
independ
physician
use
standardis
written
form
question
includ
person
inform
medic
histori
detail
sign
symptom
acut
diseas
requir
laboratori
radiolog
examin
number
day
begin
ill
posit
coronaviru
sampl
clinic
outcom
durat
hospitalis
transfer
intens
care
unit
number
day
admiss
posit
coronaviru
sampl
taken
along
durat
symptom
taken
consider
determin
nosocomi
infect
complet
examin
medic
record
classifi
basi
final
diagnosi
upper
respiratori
tract
ill
lower
respiratori
tract
ill
without
wheez
bronchiol
exacerb
asthma
data
analys
use
exact
test
qualit
data
test
quantit
data
compar
basi
type
hcov
infect
case
two
coronavirus
analys
hundr
coronavirus
detect
sampl
neg
routin
test
account
total
sampl
cohort
hcov
fourth
frequent
circul
virus
studi
rsv
rhinovirus
influenza
b
virus
fig
process
test
routin
test
neg
sampl
underestim
preval
coronavirus
exclud
detect
two
differ
virus
howev
process
allow
us
associ
describ
clinic
symptom
hcov
infect
three
sampl
posit
two
coronavirus
two
case
due
one
case
due
coronavirus
detect
everi
month
studi
howev
hcov
infect
mainli
occur
winter
spring
month
peak
februari
fig
coronavirus
detect
belong
group
belong
group
per
cent
patient
younger
year
old
age
distribut
patient
equival
age
distribut
sampl
patient
sampl
taken
patient
infect
children
includ
clinic
analysi
end
clinic
data
avail
children
one
lost
case
one
case
chose
includ
infect
group
compar
studi
clinic
epidemiolog
characterist
studi
children
thu
compar
three
group
children
summaris
tabl
age
weight
children
similar
three
group
sex
ratio
higher
group
vs
differ
bare
signific
per
cent
children
suffer
least
one
underli
chronic
condit
delay
begin
ill
admiss
hospit
day
median
durat
hospitalis
equival
three
group
day
found
evid
nosocomi
acquisit
coronaviru
two
case
first
one
femal
child
month
old
hospitalis
neonatolog
depart
prematur
nasal
aspir
sampl
day
admiss
posit
thought
left
hospit
second
case
male
child
suffer
oesophag
atresia
admit
parenter
nutrit
hospitalis
day
contract
pneumonia
day
five
nasal
aspir
sampl
first
three
posit
detect
fourth
posit
detect
last
posit
rsv
detect
hcov
identifi
mainli
children
respiratori
tract
infect
upper
respiratori
tract
infect
common
lower
respiratori
tract
infect
vs
signific
differ
clinic
present
three
coronaviru
group
low
associ
lower
respiratori
tract
ill
detect
children
none
suffer
bronchiol
without
respiratori
symptom
sampl
time
within
follow
hour
signific
number
patient
gastrointestin
infect
associ
case
rotaviru
adenoviru
detect
stool
data
shown
children
six
admit
epilect
seizur
three
suffer
underli
neurolog
diseas
famili
epilepsi
suscept
gene
agenesi
corpu
callosum
neonat
epilepsi
tempor
lobe
haemorrhag
studi
detect
associ
high
frequenc
febril
seizur
likewis
detect
found
associ
high
frequenc
croup
statist
differ
observ
laboratori
radiolog
characterist
subtyp
hcov
final
oxygenotherapi
requir
eight
children
three
children
requir
intens
care
death
report
four
known
type
human
coronavirus
detect
respiratori
specimen
sampl
hospitalis
children
franc
autumn
winter
spring
rate
consist
recent
publish
author
studi
circul
hcov
differ
popul
differ
period
year
use
differ
molecular
method
lau
et
al
hong
kong
gerna
et
al
itali
esposito
et
al
itali
garbino
et
al
switzerland
kuyper
et
al
usa
consist
also
found
studi
includ
respect
detect
four
hcov
throughout
year
peak
circul
month
temper
climat
region
studi
group
hcov
type
preval
group
hcov
type
type
repartit
found
studi
show
epidemiolog
data
hcov
epidem
must
review
specif
understand
overlap
epidem
possibl
variat
year
year
rel
incid
differ
type
must
improv
continu
studi
conduct
sever
year
necessari
howev
signific
progress
made
studi
human
coronaviru
infect
upon
develop
reliabl
current
avail
rel
inexpens
method
detect
differ
subtyp
hcov
increas
number
type
hcov
descript
new
recombin
variant
genet
variabl
virus
creat
obstacl
develop
updat
molecular
immunolog
assay
effici
strategi
molecular
methodolog
depend
upon
adequ
knowledg
limit
techniqu
consensu
method
often
use
degener
primer
defin
conserv
gene
theoret
allow
detect
type
well
potenti
detect
new
variant
howev
author
found
consensu
assay
less
sensit
method
use
primer
multiplex
pcr
provid
interest
altern
approach
test
studi
nonetheless
approach
involv
develop
classic
pcr
use
first
detect
amplifi
product
hybridis
assay
next
challeng
develop
sensit
inexpens
multiplex
pcr
must
also
kept
mind
develop
valid
monoclon
antibodi
critic
rapid
easili
avail
diagnosi
respiratori
viral
infect
detect
coronaviru
respiratori
specimen
neg
viral
routin
test
associ
upper
lower
respiratori
tract
diseas
hospitalis
children
case
respect
around
patient
eight
requir
oxygenotherapi
patholog
impact
hcov
infect
vari
accord
design
studi
popul
esposito
et
al
recent
suggest
prospect
studi
conduct
itali
differ
type
hcov
limit
clinic
impact
otherwis
healthi
children
check
emerg
ward
studi
patient
underli
chronic
diseas
exclud
hcov
mainli
associ
upper
respiratori
tract
ill
studi
also
conduct
itali
gerna
et
al
includ
patient
immunocompromis
hcov
detect
case
lower
respiratori
tract
ill
upper
respiratori
tract
ill
although
hcov
may
consid
low
pathogen
virus
respons
limit
diseas
wider
popul
treat
gener
practition
studi
show
nearli
children
admit
hospit
respiratori
tract
ill
suffer
underli
chronic
condit
prove
consider
risk
complic
hcov
may
also
respons
respiratori
nosocomi
infect
therefor
critic
hcov
screen
routin
respiratori
specimen
hospit
reliabl
viral
detect
method
use
compar
analysi
clinic
symptom
associ
detect
differ
hcov
type
suggest
type
frequent
detect
studi
less
often
associ
lower
respiratori
diseas
type
could
detect
larger
rang
diseas
data
consist
recent
report
find
associ
bronchiol
pneumonia
hospitalis
children
detect
specif
patholog
pattern
hcov
type
remain
thoroughli
investig
previous
show
like
probabl
type
excret
stool
unfortun
stool
sampl
enrol
children
avail
could
test
hcov
shed
hcov
gastrointestin
tissu
probabl
play
determin
role
viral
transmiss
could
respons
diseas
patient
hcov
also
suspect
play
role
neurolog
diseas
may
play
role
epilect
seizur
associ
found
studi
nevertheless
potenti
neurotrop
hcov
strain
gener
merit
investig
sum
hcov
detect
peopl
without
respiratori
viru
detect
associ
upper
respiratori
tract
ill
signific
rate
lower
respiratori
tract
ill
hospitalis
children
children
suffer
underli
chronic
diseas
four
type
hcov
detect
new
type
repres
substanti
portion
detect
multiplex
develop
studi
enabl
sensit
detect
characteris
known
hcov
type
except
